Relationship between treatment response of initial DMARD and outcome of treat-to-target strategy in patients with early rheumatoid arthritis: Nationwide Inception Cohort of Early Rheumatoid arthritis patients in Japa
Not Applicable
Recruiting
- Conditions
- Rheumatoid Arthritis
- Registration Number
- JPRN-UMIN000031950
- Lead Sponsor
- agoya University Hospital Orthopedic Surgery
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 685
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who have been treated with MTX exceeding 6 mg or who have been treated 2) Patients who are being treated with biologic drugs or targeted synthetic antirheumatic drugs or who have been treated 3) Patients who can not comply with dosage regimen 4) Patients who are deemed inappropriate for research by the research staff
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To explore relationship between the changes in disease activity by csDMARD treatment and that of disease activity up to 24 weeks for the first adapting therapy (bDMARD / tsDMARD, or csDMARD). Also analyze by each adapting therapy. 2.To identify factors related to achieving remission at week 24. Also analyze by each adapting therapy.
- Secondary Outcome Measures
Name Time Method